Levitas Hormones for Life: How Testosterone Therapy Builds Muscle, Metabolism, and Longevity
R&D

Levitas Hormones for Life: How Testosterone Therapy Builds Muscle, Metabolism, and Longevity

Levitas Academy
14 January 2026
2 min read

Levitas Hormones for Life: How Testosterone Therapy Builds Muscle, Metabolism, and Longevity

Hormone Science

Testosterone isn’t just a reproductive hormone — it’s a foundational health hormone. It influences muscle, fat distribution, cardiometabolic health, mood, cognition, and long-term vitality.

Clinically-guided TRT can restore muscle mass, improve metabolic flexibility, support mood and energy, and slow functional aging — when delivered safely and individually.

1) Why Testosterone Declines

Men lose ~1% testosterone per year after age 30. This accelerates with:

  • Stress, poor sleep, weight gain
  • Environmental endocrine disruptors
  • Insulin resistance
  • Chronic inflammation

2) Muscle and Strength Benefits

Normal testosterone levels:

  • Increase protein synthesis
  • Preserve type II muscle fibers
  • Improve strength & physical performance
  • Reduce sarcopenia risk

Men on TRT gain 3–5 kg lean mass over 12–18 months with training support.

3) Metabolic Health

Low testosterone is linked with:

  • Increased visceral fat
  • Insulin resistance
  • Higher risk of T2 diabetes
  • Elevated cardiovascular risk

TRT improves glucose control, lowers fat mass, and increases metabolic rate.

4) Longevity & Vitality

Studies show that men with optimal testosterone:

  • Have fewer cardiovascular events
  • Maintain better bone density
  • Show less cognitive and functional decline
  • Live longer, healthier lives

5) The Levitas Approach

Not just replacing testosterone — restoring balance.

  • Deep symptom assessment
  • Advanced hormone + metabolic labs
  • Fertility-preserving protocols
  • DXA, body composition, & biological age tracking
  • Full cardiometabolic safety monitoring

We treat hormones, metabolism, and longevity as one system — because they are.

6) Who’s a Candidate?

Men with BOTH:

  • Symptoms (fatigue, low strength, low libido, poor recovery)
  • Biochemically low testosterone (confirmed twice)

7) What to Expect from TRT

Within 3–12 months:

  • Higher energy + motivation
  • Better strength and muscle tone
  • Improved metabolic markers
  • Reduced visceral fat
  • Sharper cognitive function

Safety First

  • Hematocrit monitoring
  • PSA & prostate surveillance
  • Regular labs & clinical review

Levitas Clinics delivers medical TRT with elite monitoring — the opposite of gym-based or “online-only” testosterone.

  • Hematocrit monitoring
  • PSA & prostate surveillance
  • Regular labs & clinical review

Key References

  • Snyder PJ et al. Testosterone Trials. NEJM. 2016.
  • Grossmann M. Testosterone and cardiometabolic health. J Clin Endocrinol Metab. 2018.
  • Bhasin S. Testosterone Therapy in Men with Hypogonadism. JAMA. 2018.
  • Saad F et al. Long-term testosterone therapy and mortality. World J Mens Health. 2020.
Explore Our Courses

Explore Our Courses

CPD-accredited courses in longevity, regenerative and functional medicine.

Browse Courses

More Articles

Related Posts

Vitamin D and Cognition
Wellbeing
18 August 20261 min read

Vitamin D and Cognition

Read Article
Vitamin D and the Safety of Higher Doses
R&D
18 August 20261 min read

Vitamin D and the Safety of Higher Doses

Read Article
Methylene Blue and Red Light Therapy for Neuroprotection and Wellbeing
R&D
14 January 20262 min read

Methylene Blue and Red Light Therapy for Neuroprotection and Wellbeing

Methylene Blue and Red Light Therapy for Neuroprotection and Wellbeing Summary: Methylene Blue and Red Light Therapy for Neuroprotection and Wellbeing Overview Methylene blue (MB) and red light therapy enhance mitochondrial function and provide neuroprotection. Together, they synergistically improve cognitive and overall health. Mechanism of Action Methylene Blue Electron Donor: MB donates electrons in the mitochondrial electron transport chain (ETC), enhancing oxygen delivery and ATP production. Inhibition of Nitric Oxide Synthase: Reduces nitric oxide production, stabilizing blood pressure and improving blood flow. Red Light Therapy Photon Donor: Near-infrared light penetrates tissues, stimulating cytochrome c oxidase (Complex IV), enhancing ATP synthesis and cellular respiration. Benefits Energy Levels: Improved mitochondrial function increases ATP production, enhancing physical stamina and reducing fatigue. Cognitive Function: Supports brain health, improving memory, focus, and mental clarity. Mood Regulation: MB acts as a mild MAOI, balancing neurotransmitters and alleviating depression and anxiety. Pain Management: Anti-inflammatory and analgesic effects support conditions like arthritis and migraines. Infection Control: MB’s antimicrobial properties help prevent infections and support immune resilience. Dosage and Administration Methylene Blue: 1–2 mg/kg body weight. Monitoring required above 7 mg/kg. IV dose ~50 mg weekly. Oral dose ~80 mg and titrated upward. Red Light Therapy: Applied transcranially in the 660–1064 nm red–NIR spectrum for optimal penetration. Research and Evidence Protection against Neurodegeneration Gonzalez-Lima and Auchter (2015) showed MB + NIR light enhances mitochondrial respiration and protects neurons. From Mitochondrial Function to Neuroprotection Tucker et al. (2018) demonstrated MB supports mitochondrial repair and may assist in Alzheimer’s and Parkinson’s treatment. Infrared Phototherapy Henderson and Morries (2015) found that NIR light improves cell survival, memory, and glucose metabolism. Neurological & Psychological Applications Rojas & Gonzalez-Lima (2013) showed transcranial lasers enhance blood flow and ATP production in neurons. References Gonzalez-Lima & Auchter, 2015 – Frontiers in Cellular Neuroscience Tucker et al., 2018 – Molecular Neurobiology Henderson & Morries, 2015 – Neuropsychiatric Disease and Treatment Rojas & Gonzalez-Lima, 2013 – Biochemical Pharmacology Wadsworth & Korthuis, 2012 – American Journal of Physiology Hamblin, 2017 – AIMS Biophysics Sahl et al., 2016 – Investigative Ophthalmology & Visual Science Bennett et al., 2016 – Cochrane Reviews Greco et al., 2001 – Journal of Bioenergetics Cassano et al., 2015 – Psychiatry Journal

Read Article

Keep Learning

Explore CPD-Accredited Courses

Browse the Levitas Academy course catalogue or get in touch with our team to find the right learning pathway.